Press releases

  16/12/2020 08:00
|

Quantum Genomics Signs a Strategic Contract with Delpharm

  15/12/2020 08:00
|

Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Faran

  03/12/2020 08:15
|

Very successfull Private Placement

  02/12/2020 17:45
|

Quantum Genomics Strengthens its Capital Structure and Financial Visibility

  02/12/2020 17:40
|

Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with DongWha Pharm

  02/11/2020 18:00
|

Quantum Genomics Announces End of Financing Agreement with Negma Group Ltd/Park Partners

  28/10/2020 08:00
|

Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Xediton Pharmaceuticals

  19/10/2020 08:00
|

Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Qilu Pharmaceutical

  22/09/2020 18:00
|

Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Orient EuroPharma (OEP)

  13/07/2020 08:00
|

Quantum Genomics Enrolls First Patient in Its Pivotal Phase III FRESH Trial of Firibastat in Difficult-to-treat and Resistant Hypertension

  06/05/2020 18:00
|

Quantum Genomics Announces Interim Analysis from Study of Firibastat in Renal Failure Patients

  07/04/2020 18:00
|

Quantum Genomics Provides Update on the Impact of the COVID-19 Health Crisis on Clinical Research Activities

  26/03/2020 18:15
|

Quantum Genomics Secured New Financing, Published its Financial Statements for Fiscal Year 2019 and Provides 2019 Highlights

  28/01/2020 07:30
|

Quantum Genomics Appoints Benoît Gueugnon as Vice President of Finance

  15/01/2020 18:00
|

Quantum Genomics to Present at the Gordon Research Conference 2020 Dedicated to the Renin Angiotensin Aldosterone System